RCKT — Rocket Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $251.38m
- -$11.09m
U.S. STOCKS ON THE MOVE-Exxon Mobil, Mondelez International, Macy's
Rocket Pharmaceuticals falls after upsized $165 mln stock offering
Brief: Rocket Pharmaceuticals Announces Proposed Public Offering Of Common Stock
Rocket Pharmaceuticals Inc reports results for the quarter ended in January 1 - Earnings Summary
Brief: Rocket Pharmaceuticals Announces Appointment Of Mikael Dolsten, M.D., Ph.D., To Board Of Directors
Brief: Rocket Pharmaceuticals Files For Mixed Shelf, Size Not Disclosed
Rocket Pharmaceuticals Inc expected to post a loss of 74 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Ardelyx, Eli Lilly, Tesla
U.S. RESEARCH ROUNDUP-AT&T, ATI, California Resources
U.S. STOCKS ON THE MOVE-Infinera, Landbridge, Tempus AI
U.S. STOCKS ON THE MOVE-ARS Pharma, Digital Realty, Capricor Therapeutics
U.S. STOCKS ON THE MOVE-Protagonist Therapeutics, Infinera, GEO Group
Rocket Pharma tumbles as FDA declines to approve its immune disorder gene therapy
US FDA declines to approve Rocket Pharma's immune disorder gene therapy (updated)
US FDA declines to approve Rocket Pharma's immune disorder gene therapy
Brief: Rocket Pharmaceuticals Presents Positive Data From LV Hematology Portfolio At The 27th Annual Meeting Of The American Society Of Gene And Cell Therapy
Rocket Pharmaceuticals Inc expected to post a loss of 68 cents a share - Earnings Preview
Brief: Rocket Pharmaceuticals Announces European Medicines Agency Acceptance Of Rp-l102 Marketing Authorization Application For The Treatment Of Fanconi Anemia
Brief: Rocket Pharmaceuticals Announces Appointment Of Aaron Ondrey As Chief Financial Officer And Additional Updates To Corporate Leadership Team